A rapidly developing paradigm for modern health care is a proactive and individualized
response to patients' symptoms, combining precision diagnosis and personalized treatment …

Asthma is a complex respiratory disease considered as the most common chronic condition
in children. A large genetic contribution to asthma susceptibility is predicted by the clustering …

Abstract Background Atopic Dermatitis (AD) is a highly pruritic, chronic-recurrent
inflammatory skin condition associated with erythematous lesions that affect a significant …

Background Inhaled corticosteroids (ICS) are the most widely prescribed and effective
medication to control asthma symptoms and exacerbations. However, many children still …

Background Long‐acting beta2‐agonists (LABA) are recommended in asthma therapy;
however, not all asthma patients respond well to LABA. We performed a systematic review …

There is wide variability in the response to inhaled corticosteroids (ICS) in asthma. While
some of this heterogeneity of response is due to adherence and environmental causes …

More than a decade has passed since the finalization of the Human Genome Project. Omics
technologies made a huge leap from trendy and very expensive to routinely executed and …

Rationale Substantial variability in response to asthma treatment with inhaled corticosteroids
(ICS) has been described among individuals and populations, suggesting the contribution of …

Introduction: Asthmatic patients show a large heterogeneity in response to asthma
medication. Rapidly evolving genotyping technologies have led to the identification of …

Asthma is a chronic respiratory disease that affects 339 million people worldwide and has a
considerable impact on the pediatric population. Asthma symptoms can be controlled by …